Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10q0618ex32ii_actiniumpharm.htm |
| EX-32.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10q0618ex32i_actiniumpharm.htm |
| EX-31.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10q0618ex31ii_actiniumpharm.htm |
| EX-31.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10q0618ex31i_actiniumpharm.htm |
| EX-10.2 - EMPLOYMENT AGREEMENT, DATED AUGUST 8, 2018, BETWEEN STEVE O'LOUGHLIN AND ACTINIU - Actinium Pharmaceuticals, Inc. | f10q0618ex10-2_actinium.htm |
| EX-10.1 - EMPLOYMENT AGREEMENT, DATED AUGUST 8, 2018, BETWEEN SANDESH SETH AND ACTINIUM PH - Actinium Pharmaceuticals, Inc. | f10q0618ex10-1_actinium.htm |
| EX-3.1 - AMENDED AND RESTATED BYLAWS OF ACTINIUM PHARMACEUTICALS, INC., DATED AUGUST 8, 2 - Actinium Pharmaceuticals, Inc. | f10q0618ex3-1_actinium.htm |
| 10-Q - QUARTERLY REPORT - Actinium Pharmaceuticals, Inc. | f10q0618_actiniumpharma.htm |
Exhibit 16.1
United States Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Ladies and Gentleman:
We have read the statements under Item 4.01 included in Item 5 - Other Information in the Form 10-Q of Actinium Pharmaceuticals, Inc. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We have no basis to agree or disagree with the other statements made by the Company in Item 5 - Other Information in the Form 10-Q
Sincerely,
/s/GBH CPAs, PC
GBH CPAs, PC
www.gbhcpas.com
Houston, Texas
August 9, 2018